Skip to main content

Quark Closes $10M Private Financing Round

Premium

Quark Pharmaceuticals said this week that it has closed a $10 million round of private financing.

The company said it will use the funds to advance its RNAi drug pipeline, which includes the phase I acute renal failure treatment QPI 1002, which is also under phase I/II development for the prevention of delayed graft function; and QPI 1007, a phase I ocular neuroprotectant.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.